Keyphrases
Canine
100%
Radiation Therapy
80%
Sarcoma Cells
53%
Computed Tomography
52%
Feline Injection-site Sarcoma
42%
Chemotherapy
37%
Doxorubicin
36%
Veterinary
36%
Metastasis
32%
Non-Hodgkin Lymphoma
29%
Cell Viability
29%
Cancer Treatment
28%
Tumor
24%
Cancer-related Cognitive Impairment
24%
Canine Cancer
23%
Masitinib
22%
Pet Dogs
21%
Lymphoma
21%
Mast Cell Tumor
20%
Intensity-modulated Radiation Therapy
20%
Radiotherapy
20%
Positron Emission Tomography-computed Tomography (PET-CT)
19%
Sarcoma
18%
Radiation Oncology
17%
Antiproliferative Activity
17%
Apoptotic Activity
17%
Oral Neoplasia
17%
Brachytherapy Device
17%
Superficial Brachytherapy
17%
Median Survival Time
16%
Transitional Cell Carcinoma
15%
High Risk
15%
GS-9219
14%
Clinical Benefit
14%
18F-fluorothymidine
14%
Comparative Oncology
14%
Injection-site Sarcoma
14%
Tolerability
14%
Helical Tomotherapy
14%
Adenocarcinoma
13%
Tumor Volume
13%
Cancer Cells
13%
Feline
13%
Positron Emission Tomography
13%
Radiation Effects
12%
Canine Osteosarcoma
12%
Osteosarcoma Cells
12%
Neck Dissection
12%
Lymph Node
12%
6-year-olds
12%
Medicine and Dentistry
Radiation Therapy
51%
Neoplasm
37%
Malignant Neoplasm
35%
Injection Site
26%
Masitinib
22%
Sarcoma Cell Line
20%
Diseases
18%
Cognitive Defect
18%
Intensity Modulated Radiation Therapy
17%
Brachytherapy
17%
Computer Assisted Tomography
17%
Cell Viability
14%
Connective Tissue Cancer
12%
In Vitro
12%
Cancer Therapy
12%
Pulmonary Fibrosis
11%
Cell Line
11%
Tomotherapy
11%
Sarcoma Cell
11%
Yttrium 90
10%
Lung
10%
Idiopathic Pulmonary Fibrosis
10%
Neuroinflammation
10%
BRCA2
8%
Leukocyte
8%
Spindle Cell Carcinoma
8%
Cancer Epidemiology
8%
Cell Death
8%
Hypofractionated Radiotherapy
8%
Orbital Inflammation
8%
Mechanistic Target of Rapamycin
8%
Glioblastoma
8%
Prostate Cancer
8%
Image Analysis
8%
Positron Emission Tomography-Computed Tomography
8%
Positron Emission Tomography
8%
Cancer Diagnosis
8%
Myeloid-Derived Suppressor Cell
8%
Doxorubicin
8%
Tyrosine Kinase Receptor
8%
Neck Dissection
8%
Cervical Lymph Node
8%
Medicine
8%
Cancer Treatment
8%
Fibroblast
8%
Radiation Dermatitis
8%
Keloid
8%
Non Melanoma Skin Cancer
8%
Platelet Derived Growth Factor Receptor
7%
Immunohistochemistry
6%